The architecture of the body is not encoded as a formal blueprint; rather, it's the tightly orchestrated activation and ...

BOSTON, Aug. 20, 2025 /PRNewswire/ -- Somite.ai, a company pioneering foundation models for human stem cells, today announced a strategic investment from AMD Ventures, following Somite's $47M Series A ...

You may take for granted the fact that your body isn't the same from head to toe. Have you stopped and wondered why? Controlling gene expression to turn on and off at specific times is no simple feat.

CDMO collaboration propels cell replacement therapy targeting Duchenne muscular dystrophy forward, with consequences for the role of AI in cell therapy "I am excited about the long-term potential of ...

New white paper details key technical milestones and validation of the company's proprietary, capsule-based platform to accelerate breakthroughs across human health BOSTON, Jan. 7, 2026 /PRNewswire/ - ...

Founded in October 2023, Somite is building AI foundation models to produce human tissue at scale for cell therapies. These therapies have the potential to cure a wide range of diseases that involve ...

BOSTON, May 13, 2025 /PRNewswire/ -- Somite AI, a TechBio company leveraging foundation models and proprietary AI to accelerate human cell therapy development, closed its Series A funding round, ...

Forbes contributors publish independent expert analyses and insights. Gil Press writes about technology, entrepreneurs and innovation. Five scientists walked into a lab late last year and decided to ...

Somite is transforming cell therapy by building large-scale foundation models to rapidly accelerate the development of novel cell therapies, significantly compressing timelines and potentially ...